Non-producer human cells induced by murine sarcoma virus.
about
Transfer of the gene for thymidine kinase to thymidine kinase-deficient human cells by purified herpes simplex viral DNAGibbon ape leukemia virus-Hall's Island: new strain of gibbon ape leukemia virusEukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymeraseNuclear pseudogenes of mitochondrial DNA as a variable part of the human genome.Expression of the cholecystokinin gene in pediatric tumors.Human granulocyte-macrophage colony-stimulating factor is a growth factor active on a variety of cell types of nonhemopoietic origin.Herpes simplex virus gD and virions accumulate in endosomes by mannose 6-phosphate-dependent and -independent mechanisms.Immunization with a single major histocompatibility complex class I-restricted cytotoxic T-lymphocyte recognition epitope of herpes simplex virus type 2 confers protective immunity.Functional analysis of the 5' flanking sequence of a vaccinia virus late gene.A novel herpes simplex virus glycoprotein, gL, forms a complex with glycoprotein H (gH) and affects normal folding and surface expression of gH.Identification and characterization of a novel herpes simplex virus glycoprotein, gK, involved in cell fusionAn endoplasmic reticulum-targeting signal sequence enhances the immunogenicity of an immunorecessive simian virus 40 large T antigen cytotoxic T-lymphocyte epitope.Raccoon poxvirus recombinants expressing the rabies virus nucleoprotein protect mice against lethal rabies virus infectionEndothelial cell expression of testican mRNA.Loss of (2'-5')oligoadenylate synthetase activity by production of antisense RNA results in lack of protection by interferon from viral infections.Silencing of CD44 gene expression in human 143-B osteosarcoma cells promotes metastasis of intratibial tumors in SCID miceNatural antibodies in sera from healthy humans to antigens on surfaces of type C RNA viruses and cells from primates.Kinome and mRNA expression profiling of high-grade osteosarcoma cell lines implies Akt signaling as possible target for therapy.Identification of unintegrated forms of Kirsten murine sarcoma viral DNA and restriction endonuclease cleavage map of linear DNA.Genomic instability of osteosarcoma cell lines in culture: impact on the prediction of metastasis relevant genes.Simian virus 40 large T antigen contains two independent activities that cooperate with a ras oncogene to transform rat embryo fibroblastsCross-protection of mice against a global spectrum of rabies virus variants.A recombinant vaccinia virus encoding inducible nitric oxide synthase is attenuated in vivo.Identification of active-site residues in protease 3C of hepatitis A virus by site-directed mutagenesis.Mapping of the vaccinia virus thymidine kinase gene by marker rescue and by cell-free translation of selected mRNADifferential expression of the amv gene in human hematopoietic cellsOncogenes in human tumor cell lines: molecular cloning of a transforming gene from human bladder carcinoma cells.Vaccinia virus: a selectable eukaryotic cloning and expression vector.Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Identification of the anti-viral activity as interferon and characterization of the human effector lymphocyte subpopulation.Interferon gamma is involved in the recovery of athymic nude mice from recombinant vaccinia virus/interleukin 2 infection.Genes regulated in metastatic osteosarcoma: evaluation by microarray analysis in four human and two mouse cell line systems.Selective assay for herpes simplex viruses expressing thymidine kinase.Isolation and characterization of an endogenous type C RNA virus of mink (Mv1Lu) cellsMurine xenotropic type C viruses I. Distribution and further characterization of the virus in NZB mice.Rabies virus antinucleoprotein antibody protects against rabies virus challenge in vivo and inhibits rabies virus replication in vitroIdentification of an immunodominant cytotoxic T-lymphocyte recognition site in glycoprotein B of herpes simplex virus by using recombinant adenovirus vectors and synthetic peptides.The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle.Regulated expression of foreign genes in vaccinia virus under the control of bacteriophage T7 RNA polymerase and the Escherichia coli lac repressor.Utilization of DNA recombination for the two-step replacement of growth factor sequences in the vaccinia virus genome.Limited expression of poliovirus by vaccinia virus recombinants due to inhibition of the vector by proteinase 2A.
P2860
Q24561747-A6883497-163D-4565-881D-31C142BD1D5EQ24594909-CF5EF7E5-427D-4E53-8B0F-A7A553E59BCAQ27860943-0EF98F9A-E3AD-4B3D-9CB4-9F866CA187AAQ30831922-6DBAAF18-A082-4A9F-A2E4-A809AE574EF9Q33611504-FDE82B91-1DD9-4C1F-A549-EB22F18A45CDQ33682051-42F8A1F5-5165-4120-A89B-11BD5AC5F9C8Q33783423-DF2106C7-2430-474B-B48A-B618BAB2AD09Q33785966-A4C7CAF2-38D4-4202-AC9A-A95BD0FBBC98Q33880222-7C79379D-9799-4A38-B7E0-63303C3D8496Q33931805-FBA97C33-E722-4045-92DF-A6C9F984F288Q33936959-22F2FA72-020D-4E24-97F5-74CD45EAC2BBQ34069951-369309BB-7C1F-460D-805E-C55FD996FBD4Q34106638-ACFA3B2F-8C37-495F-9AC8-C43F15D1ABC8Q34436996-A2DD924A-6ABA-4524-8856-7394C2F7E338Q34591679-40357B50-F67C-4B78-AC15-38FE3C8FEA65Q34658335-BEA2605D-FFB8-4AD5-BBF8-D8DA7C102777Q35012236-89CB02A8-72D1-4DD9-B680-9214DFE0727EQ35085839-A5662745-8CED-419B-89ED-834C96B418D8Q35238043-18C7B897-85FD-48D7-8696-F2F87A543700Q35625523-C58A0B90-E206-4F41-B63E-AB1CCFFF0B77Q35831951-CE087F9E-64ED-4DA6-8480-C7AE1663BB1FQ35845061-42EB0409-5254-4CD1-AC1E-D27EE0C44184Q35872019-EFBC1595-CDF9-4319-8690-9FA5D447A629Q35881158-30256E93-B151-43F6-868E-630FB44773C3Q36282848-52BC4F92-CF4B-49CF-A432-EBD69000D6B5Q36289210-1C56D608-2611-448C-8975-9225AC37B093Q36293758-F92B871A-9BC1-4859-8030-DE3CEF254B91Q36324116-CF36570A-DB7A-4241-AD22-C69CB5B1BC66Q36340292-F6E469F6-1296-4B63-8AC2-8364C220CCDDQ36353800-38DA04CB-0F5A-4D57-B643-53DAB16011A7Q36418077-A999BF7C-40CD-46DB-B628-5935F3DFA0BDQ36500550-5252BE8A-77A6-4D85-9722-EBB8F9BE782EQ36514833-70A6087E-ADF6-4BE6-8BDC-6CD8CB2B089EQ36540778-FAEC7F3E-AA65-418B-B210-8458B5A35DF7Q36653651-3E772681-581B-444D-8695-7AAC34EFC76EQ36681639-74C8A276-42B9-4A16-8FC1-7AF0202BFC59Q36687455-F88AD393-0D59-43DF-8495-170BDB42452FQ36697418-B92F268D-777F-4703-9224-F214C86CF022Q36797598-BF4542B7-147A-486C-A4CD-7D7BE3AA60F9Q36802770-5CAC9B1E-BA00-4D77-928D-EA8171FA7B5C
P2860
Non-producer human cells induced by murine sarcoma virus.
description
1975 nî lūn-bûn
@nan
1975年の論文
@ja
1975年論文
@yue
1975年論文
@zh-hant
1975年論文
@zh-hk
1975年論文
@zh-mo
1975年論文
@zh-tw
1975年论文
@wuu
1975年论文
@zh
1975年论文
@zh-cn
name
Non-producer human cells induced by murine sarcoma virus.
@en
Non-producer human cells induced by murine sarcoma virus.
@nl
type
label
Non-producer human cells induced by murine sarcoma virus.
@en
Non-producer human cells induced by murine sarcoma virus.
@nl
prefLabel
Non-producer human cells induced by murine sarcoma virus.
@en
Non-producer human cells induced by murine sarcoma virus.
@nl
P2093
P356
P1476
Non-producer human cells induced by murine sarcoma virus.
@en
P2093
P356
10.1002/IJC.2910150104
P577
1975-01-01T00:00:00Z